Process and socially competent management of innovative development of enterprise system

У монографії представлено результати дослідження й систематизації теоретичних, науково-методологічних і практичних положень та розробок що-до процесного та соціально-компетентного управління інноваційним розвитком підприємницьких систем. Запропоновано і обґрунтовано теоретико-методологічні засади процесного та соціально-компетентного управління інноваційним розвитком підприємства, визначено сучасні реалії та тенденції інноваційного розвитку підприємницьких систем, запропоновано нові підходи у корпоративному управлінні, обґрунтовано доцільність використання реінжинірингу бізнес-процесів підприємницьких систем, визначено підходи до формування корпоративної культури та соціальної відповідальності бізнесу. Для науковців та фахівців сфери економіки та управління підприємстами. The monograph presents the results of research and systematization of theoretical, scientific-methodological and practical provisions and developments regarding process and socially competent management of innovative development of business systems. Proposed and substantiated theoretical and methodological principles of process and socially competent management of innovative development of the enterprise, current realities and trends of innovative development of business systems are determined, new approaches are proposed in corporate governance, the feasibility of using reengineering of business processes of business systems is substantiated, approaches to the formation of corporate culture and social responsibility of the business. For scholars and specialists in the field of economics and enterprise managementОпубліковано за результатами виконання теми «Інноваційний розвиток підприємств на засадах процесного та соціально-компетентного корпоративного управління» (держ. реєстрація № 0117U002301

Discharge protocol in acute pancreatitis: an international survey and cohort analysis.

There are several overlapping clinical practice guidelines in acute pancreatitis (AP), however, none of them contains suggestions on patient discharge. The Hungarian Pancreatic Study Group (HPSG) has recently developed a laboratory data and symptom-based discharge protocol which needs to be validated. (1) A survey was conducted involving all members of the International Association of Pancreatology (IAP) to understand the characteristics of international discharge protocols. (2) We investigated the safety and effectiveness of the HPSG-discharge protocol. According to our international survey, 87.5% (49/56) of the centres had no discharge protocol. Patients discharged based on protocols have a significantly shorter median length of hospitalization (LOH) (7 (5;10) days vs. 8 (5;12) days) p < 0.001), and a lower rate of readmission due to recurrent AP episodes (p = 0.005). There was no difference in median discharge CRP level among the international cohorts (p = 0.586). HPSG-protocol resulted in the shortest LOH (6 (5;9) days) and highest median CRP (35.40 (13.78; 68.40) mg/l). Safety was confirmed by the low rate of readmittance (n = 35; 5%). Discharge protocol is necessary in AP. The discharge protocol used in this study is the first clinically proven protocol. Developing and testifying further protocols are needed to better standardize patients' care

Discharge protocol in acute pancreatitis : an international survey and cohort analysis

There are several overlapping clinical practice guidelines in acute pancreatitis (AP), however, none of them contains suggestions on patient discharge. The Hungarian Pancreatic Study Group (HPSG) has recently developed a laboratory data and symptom-based discharge protocol which needs to be validated. (1) A survey was conducted involving all members of the International Association of Pancreatology (IAP) to understand the characteristics of international discharge protocols. (2) We investigated the safety and effectiveness of the HPSG-discharge protocol. According to our international survey, 87.5% (49/56) of the centres had no discharge protocol. Patients discharged based on protocols have a significantly shorter median length of hospitalization (LOH) (7 (5;10) days vs. 8 (5;12) days) p < 0.001), and a lower rate of readmission due to recurrent AP episodes (p = 0.005). There was no difference in median discharge CRP level among the international cohorts (p = 0.586). HPSG-protocol resulted in the shortest LOH (6 (5;9) days) and highest median CRP (35.40 (13.78; 68.40) mg/l). Safety was confirmed by the low rate of readmittance (n = 35; 5%). Discharge protocol is necessary in AP. The discharge protocol used in this study is the first clinically proven protocol. Developing and testifying further protocols are needed to better standardize patients’ care.Peer reviewe